FDA “Safety First” Initiative, Agency’s Requests Draw Doubts From DeLauro
This article was originally published in The Tan Sheet
Executive Summary
FDA is implementing the Safety First initiative to "ensure that significant post-market safety issues are our highest priority," according to acting Center for Drug Evaluation and Research Director Janet Woodcock